Description
Uses of Medicine:
Gefitinib 250 mg is an antineoplastic medicine belonging to the tyrosine kinase inhibitors. Patients, Healthcare Professionals, or Hospitals can buy Gefitinib 250 MG Tablets online from India through THE INDIAN PHARMA (a trusted Gefitinib Supplier, Exporter, and Contract Manufacturer in India) for the management and treatment of- patients with metastatic non-small cell lung cancer (NSCLC)
Gefitinib 250 mg is a tyrosine kinase inhibitor prescribed for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations. Non-small-cell lung cancer (NSCLC) refers to a condition in which lung tissues constitute an uncontrollable cancerous growth. This condition can also metastasize to other areas of the body. Generally, treatment is given to patients with advanced-stage NSCLC who are found to have EGFR gene mutations. Moreover, treatment is also given to naïve patients who have not received any prior therapy.
Some formulations of this therapeutic drug may contain lactose, which could be problematic for patients with an intolerance to sugar. Lactose is a sugar people with certain medical conditions struggle to digest. If this is your case, let your doctor know before starting the medication. For those who cannot tolerate it, symptoms such as abdominal bloating and pain can potentially develop.
If you have kidney or liver disease, problem with your eyesight, or have any lung health issues, you are advised to seek medical consultation before using this drug. Furthermore, if you use anticoagulant agents such as warfarin, inform your healthcare practitioner as well. Blood examinations become essential to tracking complications that might arise.
Refrain from using alcohol while on treatment with Gefitinib 250 mg tablets as it may bring about increased lightheadedness and other side effects.
Be certain to tell your physician if you are currently pregnant or trying to conceive before initiating this treatment. This medicinal product may damage the fetus. A pregnancy test will be done before treatment begins. Effective contraceptive methods must be followed during the treatment and continued for two weeks after the last dose.
While on treatment with Gefitinib 250 mg tablets, breastfeeding should be avoided. As it is unclear whether the drug is transferred into breast milk, it is advisable to avoid breastfeeding. Your healthcare provider (HCP) will tailor their treatment to ensure their patient’s safety, so be sure to follow all of their recommendations.
Dosage & Side Effects:
The recommended dosage of Gefitinib is 250 mg taken orally once daily. It can be taken with or without food. It is not advisable to crush, open, or dissolve the tablet. Swallow it whole with a glass of water. Take the tablet at the same time every day. Continue the treatment until there is evidence of disease progression or if side effects become unacceptable. If you missed a dose, do not take it if it is less than 12 hours from your next scheduled dose. Adhere to your doctor’s recommendations, and take the medicine at the same time every day for optimal results. Reach out to your healthcare practitioner (HCP) whenever there’s a need for clarifying questions for your treatment. The most common side effects of Gefitinib 250 mg oral tablets are skin reactions and diarrhea.
